Delivery Order SPE2DB22D9244-SPE2DB25FZS42

This delivery order for $4,311.35, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered by October 12, 2023. The firm fixed price contract has no set-aside designation. XTANDI is used to treat men with prostate cancer and this order will support the Defense Logistics Agency's medical supply needs. DMS Pharmaceutical Group Inc. will deliver the products from their facility in Park Ridge,...

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE. The order has a potential value of $77,604.30 under a firm fixed price arrangement. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 16, 2023. No set-aside designation was applied to this award made in support of the Defense Logistics Agency's pharmaceutical procurement and distribution programs.

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. The order is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to a location in Park Ridge, Illinois. XTANDI is used to treat men with prostate cancer. The period of performance for this order is from August 29, 2023 through August 30, 2023. No subcontractors or set aside designations were...

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 120 capsules of XTANDI 40 MG CAPSULE for a potential value of $8,622.72. The delivery order was awarded on November 30, 2023 and has a completion date of December 1, 2023. Performance will take place in Park Ridge, Illinois. No set-aside designation was used for this award issued by the Defense Logistics Agency...

The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. valued at approximately seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois and is required to be completed by May 2, 2023. The order was awarded on May 1, 2023 under an existing contract vehicle and no set-aside designation was applied. XTANDI...

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $8,643.02. The place of performance is Park Ridge, Illinois and all items are to be delivered by November 10, 2022. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement, distribution and supply chain management for the...

The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois with completion by May 5, 2023. The firm fixed price contract was awarded on May 4, 2023 without a set-aside designation. As the DLA supports military treatment facilities, this order for the prostate...

The Defense Logistics Agency Troop Support Medical awarded a $4,311 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 mg for prostate cancer treatment. The one-day contract has a period of performance from August 30 to August 31, 2023, with all products to be delivered from the contractor's facility in Park Ridge, Illinois. No set aside provisions or subcontractors were identified. This order is likely in support of the Defense Health Agency's...

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-seven thousand six hundred four dollars and thirty cents ($77,604.30) by the Defense Logistics Agency to supply XTANDI 40 MG CAPSULE 120S. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceutical and medical supplies with a potential value of up to five million dollars through December 2025. No...

The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand, eight hundred sixty-eight dollars and ten cents ($25,868.10) to DMS Pharmaceutical Group Incorporated. The order is for one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE to be delivered to a location in Park Ridge, Illinois by September 28, 2023 in support of Department of Defense requirements. No set aside designation or subcontractors were identified. The award utilizes an existing...